Uterine Fibroids Treatment Market: Hysterectomy to Remain Most Preferred Treatment Procedure Through 2024
The U.S. uterine fibroids market shows a strong presence of players. The top three players in the market are Boston Scientific Corporation, Smith & Nephew, and Hologic, Inc., who hold a share of nearly 50% in the overall market. The players are focused mergers and acquisitions to broaden their product portfolio and integration of knowledge base. To remain dominant players are anticipated to lay emphasis on product differentiation. The report published by Transparency Market Research states that the U.S. uterine...
View full press release